The Schwab U.S. Dividend Equity ETF (SCHD) is known for quality dividend stocks with 105 holdings and a low fee of 0.06%. However, its top 10 holdings make up about 42% of the fund, creating concentration risks, especially in pharma facing patent cliffs and energy stocks sensitive to oil prices. While SCHD has outperformed the S&P 500 this year, it has lagged over five years. Compared to Vanguard's VYM, which offers broader diversification with over 550 stocks, SCHD is more focused but may expose investors to sector-specific risks. Investors seeking diversification should consider pairing SCHD with other ETFs or alternatives like VYM.
The SCHD ETF has returned just under 2% in the past month, outperforming the S&P 500 ETF (SPY) by nearly 1%. Year-to-date, about 30 SCHD holdings have more than doubled the returns of SPY, which has returned 9.8%. Additionally, 31 SCHD holdings are t...
The Schwab U.S. Dividend Equity ETF (SCHD) has gained 20% year-to-date, outperforming the S&P 500's 10% rise. SCHD focuses on large-cap companies with strong dividend histories and value metrics, avoiding mega-cap tech stocks that led recent market r...
